Laboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.
BioEM Core Facility and Technology Platform, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982. doi: 10.1073/pnas.1913904117. Epub 2020 Feb 19.
Parkinson's disease (PD) is characterized by the accumulation of misfolded and aggregated α-synuclein (α-syn) into intraneuronal inclusions named Lewy bodies (LBs). Although it is widely believed that α-syn plays a central role in the pathogenesis of PD, the processes that govern α-syn fibrillization and LB formation remain poorly understood. In this work, we sought to dissect the spatiotemporal events involved in the biogenesis of the LBs at the genetic, molecular, biochemical, structural, and cellular levels. Toward this goal, we further developed a seeding-based model of α-syn fibrillization to generate a neuronal model that reproduces the key events leading to LB formation, including seeding, fibrillization, and the formation of inclusions that recapitulate many of the biochemical, structural, and organizational features of bona fide LBs. Using an integrative omics, biochemical and imaging approach, we dissected the molecular events associated with the different stages of LB formation and their contribution to neuronal dysfunction and degeneration. In addition, we demonstrate that LB formation involves a complex interplay between α-syn fibrillization, posttranslational modifications, and interactions between α-syn aggregates and membranous organelles, including mitochondria, the autophagosome, and endolysosome. Finally, we show that the process of LB formation, rather than simply fibril formation, is one of the major drivers of neurodegeneration through disruption of cellular functions and inducing mitochondria damage and deficits, and synaptic dysfunctions. We believe that this model represents a powerful platform to further investigate the mechanisms of LB formation and clearance and to screen and evaluate therapeutics targeting α-syn aggregation and LB formation.
帕金森病(PD)的特征是错误折叠和聚集的α-突触核蛋白(α-syn)在神经元内聚集成路易体(LB)。虽然人们普遍认为α-syn 在 PD 的发病机制中起核心作用,但控制α-syn 纤维化和 LB 形成的过程仍知之甚少。在这项工作中,我们试图在遗传、分子、生化、结构和细胞水平上剖析 LB 生物发生所涉及的时空事件。为了实现这一目标,我们进一步开发了基于种子的α-syn 纤维化模型,以生成一种神经元模型,该模型再现了导致 LB 形成的关键事件,包括种子形成、纤维化和包含物的形成,这些包含物再现了许多真正 LB 的生化、结构和组织特征。我们使用综合组学、生化和成像方法,剖析了与 LB 形成的不同阶段相关的分子事件及其对神经元功能障碍和退化的贡献。此外,我们证明 LB 的形成涉及 α-syn 纤维化、翻译后修饰以及 α-syn 聚集体与膜细胞器(包括线粒体、自噬体和内溶酶体)之间的复杂相互作用。最后,我们表明 LB 形成过程,而不仅仅是纤维形成过程,通过破坏细胞功能和诱导线粒体损伤和缺陷以及突触功能障碍,是神经退行性变的主要驱动因素之一。我们相信,该模型代表了进一步研究 LB 形成和清除机制以及筛选和评估针对α-syn 聚集和 LB 形成的治疗方法的强大平台。